47 results
Page 2 of 3
8-K
EX-99.1
b6ct3
25 Feb 21
JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million
4:05pm
8-K
EX-99.1
aadf3b98zarsnr46
2 Feb 21
JanOne Announces Closing of $6.0 Million Common Stock Offering
5:27pm
424B5
e4f28liks
2 Feb 21
Prospectus supplement for primary offering
1:30pm
8-K
EX-99.1
b89prfpin 0r8fw3j
29 Jan 21
JanOne Prices $6.0 Million Common Stock Offering
9:08am
8-K
EX-99.1
4p04yjp53p38q5escf
24 Sep 20
JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study
10:45am
8-K
EX-99.1
gtcus1fe7nk n8p
16 Sep 20
JanOne Announces Strategic Plan to Divest its Legacy Businesses
4:29pm
8-K
EX-99.1
awg1nu p2
3 Sep 20
Other Events
1:30pm
8-K
EX-99.1
wl31mh
26 Aug 20
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
6:01am
8-K
EX-99.2
g0oflp yeui
12 Aug 20
Regulation FD Disclosure
6:03am
8-K
EX-99.1
ee3qlz
6 Aug 20
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
2:45pm
8-K
EX-99.1
i9tx29
30 Jul 20
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
9:42am
8-K
EX-99.1
8tkebusfox
21 Jul 20
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
9:25am
8-K
EX-99.1
ebfqej
8 Jul 20
Other Events
9:31am
8-K
EX-99.1
w3ikuvterc49f2xgn
30 Jun 20
One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board
9:31am
8-K
EX-99.1
znr a0ar7
25 Jun 20
Other Events
10:00am
8-K
EX-99.1
7tjhawwz6j3s
18 Jun 20
JanOne Launches Strategic Alternatives Process for Legacy Businesses
9:38am
8-K
EX-99.1
v7ai7w 93i1o
7 Feb 20
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development
12:00am